ArticleBone marrow transplantation2025

Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma.

Yetian Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.